SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Maharashtra FDA suspends manufacturing at Sequent Scientific’s Mahad unit

17 Jun 2016 Evaluate

The Maharashtra Food and Drug Administration (FDA) has ordered suspension of the manufacturing at the Mahad unit of Sequent Scientific for a period of 15 days, starting July 1 to July 15, 2016. The company is hopeful of getting the process completed in the next couple of days. In the meantime, the unit continues to operate and the company expects no business interruptions.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals.

Viyash Scientific Share Price

208.90 0.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×